Radiotherapy as a bridging strategy for patients with relapsed or refractory large B‐cell lymphoma undergoing <scp>CAR</scp> T‐cell therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Radiotherapy as a bridging strategy for patients with relapsed or refractory large B‐cell lymphoma undergoing CAR T‐cell therapy

Published:2024-06-11 Issue:9 Volume:99 Page:1837-1840
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:American J Hematol

Author:

Ababneh Hazim S.¹^ORCID,Ng Andrea K.²,Frigault Matthew J.³,Jacobson Caron A.⁴,Patel Chirayu G.¹

Affiliation:

1. Department of Radiation Oncology Massachusetts General Hospital, Harvard Medical School Boston Massachusetts USA

2. Department of Radiation Oncology Brigham and Women's Hospital Boston Massachusetts USA

3. Division of Hematology & Oncology Massachusetts General Hospital, Harvard Medical School Boston Massachusetts USA

4. Department of Medical Oncology Dana‐Farber Cancer Institute Boston Massachusetts USA

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.27409

Reference6 articles.

1. Assessing the role of radiotherapy in patients with refractory or relapsed high-grade B-cell lymphomas treated with CAR T-cell therapy

2. Bridging therapy prior to axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma

3. Effective bridging therapy can improve CD19 CAR-T outcomes while maintaining safety in patients with large B-cell lymphoma

4. Salvage radiotherapy in relapsed/refractory large B-cell lymphoma after failure of CAR T-cell therapy

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report: Bridging radiation therapy before chimeric antigen receptor T-cell therapy induces sustained remission in patients with relapsed/refractory double-expressor diffuse large B-cell lymphoma with localized compressive symptoms;Frontiers in Immunology;2024-09-03

2. Adaptive bridging radiation therapy for relapsed/refractory B-cell lymphoma patient undergoing CAR T-cell therapy: Case report;Clinical and Translational Radiation Oncology;2024-09

3. On Route to Chimeric Antigen Receptor T-cell (CAR T) Therapy, Less Is More: Adaptive Bridging Radiotherapy in Large B-cell Lymphoma;Cureus;2024-08-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3